BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3922019)

  • 1. Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas.
    Malaisse WJ; Mathias PC; Malaisse-Lagae F; Sener A
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):265-84. PubMed ID: 3922019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of extracellular pH upon the ionic and secretory response to gliclazide in pancreatic islets.
    Billaudel B; Mathias PC; Lebrun P; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):139-58. PubMed ID: 6422527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
    Kawazu S; Sener A; Couturier E; Malaisse WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):277-83. PubMed ID: 6995864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of a calcium-agonist and hypoglycemic or hyperglycemic sulfonamides upon insulin release.
    Malaisse WJ; Sener A; Malaisse-Lagae F
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):71-83. PubMed ID: 3898259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cationic and secretory response of pancreatic islets to gliclazide and/or potassium.
    Mathias PC; Billaudel B; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):389-400. PubMed ID: 6320319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modalities of gliclazide-induced Ca2+ influx into the pancreatic B-cell.
    Lebrun P; Malaisse WJ; Herchuelz A
    Diabetes; 1982 Nov; 31(11):1010-5. PubMed ID: 6757009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
    Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F
    J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D-glucose during preincubation of pancreatic islets with 45Ca upon the subsequent stimulation of 45Ca outflow by hypoglycemic sulfonylureas and K+.
    Malaisse WJ; Sener A
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):365-78. PubMed ID: 3517988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets.
    Louchami K; Jijakli H; Sener A; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):155-68. PubMed ID: 9583090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of a tumor-promoting phorbol ester and a hypoglycemic sulfonylurea upon insulin release.
    Malaisse WJ; Lebrun P; Herchuelz A; Sener A; Malaisse-Lagae F
    Endocrinology; 1983 Nov; 113(5):1870-7. PubMed ID: 6354699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulus-secretion coupling of amino acid-induced insulin release. Metabolic interaction of L-glutamine and 2-ketoisocaproate in pancreatic islets.
    Malaisse WJ; Sener A; Malaisse-Legae F; Hutton JC; Christophe J
    Biochim Biophys Acta; 1981 Sep; 677(1):39-49. PubMed ID: 7028130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do hypoglycemic sulfonylureas inhibit Na+,K+-ATPase activity in pancreatic islets?
    Lebrun P; Malaisse WJ; Herchuelz A
    Am J Physiol; 1985 May; 248(5 Pt 1):E491-9. PubMed ID: 2581455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose both inhibits and stimulates insulin secretion from isolated pancreatic islets exposed to maximally effective concentrations of sulfonylureas.
    Panten U; Schwanstecher M; Wallasch A; Lenzen S
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):459-62. PubMed ID: 3149719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities in the stimulus-secretion coupling mechanisms of glucose- and 2-keto acid-induced insulin release.
    Hutton JC; Sener A; Herchuelz A; Atwater I; Kawazu S; Boschero AC; Somers G; Devis G; Malaisse WJ
    Endocrinology; 1980 Jan; 106(1):203-19. PubMed ID: 6985583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stimulus-secretion coupling of amino acid-induced insulin release. Secretory and oxidative response of pancreatic islets to L-asparagine.
    Malaisse-Lagae F; Welsh M; Lebrun P; Herchuelz A; Sener A; Hellerström C; Malaisse WJ
    Diabetes; 1984 May; 33(5):464-9. PubMed ID: 6373456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by corticosterone of calcium inflow and insulin release in rat pancreatic islets.
    Billaudel B; Mathias PC; Sutter BC; Malaisse WJ
    J Endocrinol; 1984 Feb; 100(2):227-33. PubMed ID: 6363591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coupling of metabolic to secretory events in pancreatic islets: inhibition by 2-cyclohexene-1-one of the secretory response to cyclic AMP and cytochalasin B.
    Malaisse WJ; Garcia-Morales P; Gomis R; Dufrane SP; Mathias PC; Valverde I; Sener A
    Biochem Pharmacol; 1986 Nov; 35(21):3709-17. PubMed ID: 2877668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.